Medtech1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 MedTech News
Tech & Innovation
Living With a Device
 Education Center
Diagnostic Tests
Conditions
Procedures
Women's Health
Companies
Online Resources
Video Library
Dr. Christopher Kwolek  MedTech  Hero™
Dr. Christopher Kwolek:
Pioneering New Blood Clot Treatments.
About Heroes
 Join the Discussion in  Our Forums
 Community
MedTech1 Forums
 Advocacy Center
Contact Congress
Find a Patient Group
 Bookmark Us
 
advertisement
Search the Body1 Network
October 29, 2020  
EDUCATION CENTER: Diagnosis and Treatment

Clinical Overview
Definition
Symptoms Diagnosis and Treatment

  • Printer Friendly Version
  • Email this Condition
  • Leukemia

    Diagnosis and Treatment
    Some people may be genetically predisposed to certain types of leukemia. Chromosomal abnormalities are associated not only with some leukemias but also with a preleukemic disease called myelodysplasia.

    Environmental risks and tobacco use also heighten the risk of developing leukemia. Also, prolonged exposure to radiation, certain chemicals, and low-frequency electromagnetic fields may raise the risk.

    Because it may display no obvious symptoms, leukemia is often diagnosed incidentally during a physical exam. Doctors will recognize enlarged lymph nodes, swollen gums, and an enlarged liver or spleen as symptoms. A blood test showing an abnormally high white blood cell count is usually enough for a tentative diagnosis. To confirm diagnosis, the patient will undergo a bone marrow aspiration and bone marrow biopsy from a pelvic bone. If CML is suspected, the patient will undergo tests to detect the Philadelphia chromosome.

    Doctors will also perform imaging tests in some people suspected to have leukemia. These tests include X-ray, CT scan, MRI, and ultrasound.

    Although the number of leukemia cases reported has remained static since the 1950s, survival rates have improved. ALL, childhood leukemia, represents a success story. Ninety percent of children diagnosed with ALL attain remission (no more cancerous cells detected) and more than half are completely cured. In the 1960s, the five-year survival rate was 4 percent; in the 1990s, it was better than 50 percent.

    Adult patients with ALL have an 80 to 90 percent chance of remission. About 40 percent who reach remission survive another five years with the chance of a full cure. Patients with AML have a 60 to 70 percent chance of remission; 20 percent survive three years with the chance of a cure.

    Patients with acute leukemia almost always undergo aggressive chemotherapy to attain remission. Treatment is administered for as long as it takes to attain remission.

    ALL patients may gain satisfactory remission after several weeks in the hospital. To control the disease, they will receive low-dose chemotherapy and possibly radiation for a period of time to eliminate residual traces of cancer. The amount of time spent on this phase of therapy is dependent upon the individual patient.

    AML does not generally respond well to chemotherapy. The best chance of a cure is bone marrow transplantation, which requires a donor with matching tissue type and genetic characteristics—usually a family member. Bone marrow transplantation can also offer a chance at remission to people with recurring cases of ALL.

    CLL treatments tend to be conservative because the disease progresses so slowly. If swelling appears in the lymph nodes or other organs, oral chemotherapy can keep the disease in check for several years. Many CLL patients lead normal lives and die of other causes.

    CML can be effectively treated with oral chemotherapy for several years before the disease moves to the acute stage. Interferon, a naturally occurring protein that kills or slows the growth of cancerous cells, can lengthen CML patients’ lives. Because CML inevitably advances to the acute phase, some doctors advise a bone marrow transplant during the chronic stage.

    CML is the more aggressive of the chronic leukemias. The average survival time is approximately four years because it escalates to the acute phase even while the patient undergoes treatment.

    Last updated: 23-Feb-07

       
    Interact on Medtech1

    Discuss this topic with others.
     
    Related Multimedia

    Interview with Dr. Chen: Gastrointestinal Cancer - Staging Cancer

    Interview with Dr. Chen - Gerd and Gastroenterology

    Interview with Dr. Saines: Diagnosing Varicose Veins 1

    More Features ...
     
    Related Content
    Testicular Cancer

    Prostate Cancer

    Ovarian Cancer

    Non-Hodgkin's Lymphoma

    Multiple Myeloma

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2020 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.